Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-15

FDA Approved: ANASTROZOLE — Supplemental Application (Natco Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for ANASTROZOLE by Natco Pharma Limited, issuing regulatory approval for a generic version of anastrozole.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anastrozole (Anastrozole)

Snippet

SUPPL AP for ANASTROZOLE (ANASTROZOLE)